TRDA
Entrada Therapeutics, Inc. · Healthcare
Chief Medical Officer Nerissa Kreher sold $31K of Entrada Therapeutics, Inc.
Sold$30,531
$15.11Price
2,021Shares
−9%Stake
What TRDA did after the filing
- The stock from Mon, Sep 12 close, $11.91
- +65.1%
- S&P 500, same days
- −7.4%
Measured over 30 trading days, to the Oct 24 close.
Traded Thu, Sep 8. Filed Mon, Sep 12, 12:18 PM ET, during the session. Returns use the Sep 12 close and the Oct 24 close. Not investment advice.